Journey Clinical recently announced that it raised $8.5 million in Series A funding in a round led by Union Square Ventures. Exbo advised Journey on its strategic growth plan through fundraising, built financial projections and KPI reports for the dataroom, and worked directly with investors to support their financial diligence requests.

Other key investors included AlleyCorp, Fifty Years, Able Partners, Gaingels, Palo Santo, PsyMed Ventures, Coalition Partners, Mystic Ventures, Colibri, Satori Capital.  

Jonathan Sabbagh, CEO of Journey, started the company with a goal of supporting therapists who were interested in providing psychedelic-assisted therapy. He said, “we built a platform that gives therapists everything they need to incorporate this into their practice. Our primary client is always the therapist."

‍